MDxHealth (O6C1.F)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 15M 30M 45M FY20: 18.5M FY21: 22.2M FY22: 37.1M FY20 FY21 FY22

Gross Profit Annual

0 7M 14M 21M FY20: 8M FY21: 10.6M FY22: 19.2M FY20 FY21 FY22

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY20: -27.1M FY21: -26.8M FY22: -37.9M FY20 FY21 FY22

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY20: -28.7M FY21: -29M FY22: -44M FY20 FY21 FY22

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY20: -20.2M FY21: -22.5M FY22: -34.1M FY20 FY21 FY22

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY20: -20.8M FY21: -23.4M FY22: -36.9M FY20 FY21 FY22

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.